Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Microstructure Imaging Receives FDA Clearance for MICSI-PET, Bringing MR-Guided ...

15 September 2026 · By · Wire by Fusion42

Published

15 September 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at biospace.com →

◆ Verified

Fusion42 · 15 September 2026 · Fusion42 review

Microstructure Imaging received FDA 510(k) clearance for MICSI-PET, the first MR-guided PET enhancement software with automated amyloid and tau quantification, improving neurological PET imaging quality and diagnostic accuracy.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You can leverage MICSI-PET's FDA clearance to enter clinical neuroimaging workflows faster and challenge existing PET tools with improved image quality and automated disease markers. This clearance opens doors for clinical partners and deployments across major MRI and PET systems you should approach now.

◆ Coverage

1 source · 15 Sep 2026

◆ Related on Wire

◆ Topics

Medtechfda-clearanceneuroimagingpet-mrimedical-softwareamyloid-tau